Trial intelligence / Profile preview

Ultrasound-Guided TAP Block in Laparoscopic Bariatric Surgery

NCT05286008Unknown

Sponsor
Tianjin Medical University General Hospital
Start
Mar 2022
Primary completion
Sep 2022
Modality
Orthosteric Ligands
01

Overview

Randomised, double-blind trial of ropivacaine in postoperative nausea and vomiting (PONV) and postoperative pain (3 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoint: Postoperative nausea and vomiting. Status: unknown.

02

Drugs

ropivacaine
03

Conditions

postoperative nausea and vomiting (PONV)postoperative pain

Beyond the preview

Go deeper on NCT05286008.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05286008.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call